|
|
|||||||
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
05-30-2015, 03:01 PM
|
|||
|
|||
Global Cervical Cancer Diag**stic Tests Market will worth of USD 8.9 billion by 2020.
Global Cervical Cancer Diag**stic Tests Market will worth of USD 8.9 billion by 2020.
According to a new Market report published by Transparency Market Research “Cervical Cancer Diag**stic Tests Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020,” the Global Cervical Cancer Diag**stic Tests Market was valued at USD 5.9 billion in 2013 and is expected to grow at a CAGR of 6.1% from 2014 to 2020, to reach an estimated value of USD 8.9 billion in 2020. Cervical Cancer develops in cervix due to ab**rmal growth of Cervical cells, and is commonly spread through a virus termed as human papillomavirus (HPV). Presently, the Cervical Cancer Diag**stic Tests Market is growing at a rapid pace due to increasing prevalence and deaths caused due to Cervical Cancer across the globe. According to the World Health Organization (WHO), Cervical Cancer accounts for deaths of more than 270,000 women each year, primarily in the developing countries. With the increasing use of Cervical Cancer Diag**stic Tests such as Pap smear tests, HPV testing and colposcopy for early detection, the Market is described as highly competitive with high growth rate. Increasing incidences of weakened immune system, rapid spread of human papillomavirus (HPV) infection among the female population and long-term use of oral contraceptive pills are the primary factors responsible for the growth of Cervical Cancer Diag**stic Tests market. Furthermore, other lifestyle-related factors such as smoking, having multiple *** partners and certain family history of Cervical Cancer are anticipated to drive the growth of the Market in the near future. The advent of tech**logically advanced computer-guided screening Tests for Cervical Cancer to reduce the rate of false-negative test results and improve accuracy would contribute to the growth of the Cervical Cancer Diag**stic Tests Market during the forecast period from 2014 to 2020. However, certain restraining factors such as lack of education regarding the prevalence of Cervical Cancer and reluctance of the female population to undergo Cervical Cancer prog**sis would hinder the growth of the market. Moreover, unfavorable taxation and lack of favorable reimbursement policies in the European and Asian countries have affected the growth of the Market negatively. For more information, Tables, figures and Segmentation, visit: http://www.transparencymarketresearc...ts-market.html The Pap smear Tests segment accounted for the largest share of over 45% of the total Cervical Cancer Diag**stic Tests Market in 2013. Factors attributed to the dominance of this lower test prices and growing awareness about Cancer diag**sis and early detection. Similarly, in terms of growth rate, the HPV testing is forecast to grow at the fastest growth rate of more than 8% from 2014 to 2020 of the Cervical Cancer Diag**stic Tests market. Rapid growth of the HPV testing segment is attributed to the increasing incidence of HPV infections and risk of ab**rmal Pap test results. Geographically, **rth America accounted for the largest share of the total Cervical Cancer Diag**stic Tests Market in 2013. However, Asia Pacific countries such as Japan, South Korea, Malaysia, Australia, Thailand, India and China are witnessing remarkable growth and are anticipated to emerge as promising markets in the near future due to increasing awareness about the diag**sis of Cervical cancer, easy Market ***********, and increasing disposable income in these developing nations. Moreover, favorable support from governments for healthcare infrastructure would boost the growth of the Cervical Cancer Diag**stic Tests Market in Asia Pacific. Requesting For sample : http://www.transparencymarketresearc...g=S&rep_id=736 High growth rate of the Cervical Cancer Diag**stic Tests Market is likely to attract various top players. Major players operating in the Cervical Cancer Diag**stic Tests Market are Abbott Laboratories, Becton, Dickinson and Company, Femasys, Inc., Hologic, Inc., Guided Therapeutics, Inc., OncoHealth Corp., Quest Diag**stics, Inc., Roche Diag**stics, QIAGEN, and Zilico Ltd. The Global Cervical Cancer Diag**stic Tests Market is segmented as follows: Cervical Cancer Diag**stic Tests Market, by Type of Tests
Transparency Market Research is a Market intelligence company providing Global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.*We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact Us : Mr. Nachiket State Tower, 90 State Street, Suite 700, Albany NY – 12207 Tel: +1-518-618-1030 USA/Canada Toll Free: 866-552-3453 Email: [email protected] Web: http://www.transparencymarketresearch.com/ The post Global Cervical Cancer Diag**stic Tests Market will worth of USD 8.9 billion by 2020. appeared first on Medgadget. ??????? ??????: Global Cervical Cancer Diag**stic Tests Market will worth of USD 8.9 billion by 2020. || ??????: rss || ??????: اسم منتداك
|
|
|
العرض الشجري